ACPU
MDT icon

Arrowgrass Capital Partners (US)’s Medtronic MDT Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-56,700
Closed -$4.58M – 343
2017
Q4 		$4.58M Buy
56,700
+55,838
+6,478% +$4.47M 0.04% 316
2017
Q3 		$6.7M Hold
862
– – 0.05% 333
2017
Q2 		$7.65M Buy
862
+806
+1,439% +$68K 0.06% 341
2017
Q1 		$451K Sell
56
-162
-74% -$12.7K ﹤0.01% 523
2016
Q4 		$1.55M Buy
+218
New +$17.1K 0.02% 392
2015
Q4 		– Sell
-50
Closed -$335K – 441
2015
Q3 		$335K Buy
+50
New +$3.68K 0.01% 411

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s MDT Position: Q3 2019 in Review

Arrowgrass Capital Partners (US) sold out of Medtronic (MDT) in Q3 2019, closing a stake of 20,281 shares — an estimated $1.98M sold.

Arrowgrass Capital Partners (US) first reported a position in MDT in Q3 2015 and held it in 8 quarters. The position peaked at $5.36M in Q3 2017. 1,645 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

  • Arrowgrass Capital Partners (US) reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 20,281 Medtronic shares in Q3 2019, an estimated $1.98M.
  • Arrowgrass Capital Partners (US) first reported a position in Medtronic in Q3 2015 and held it in 8 quarters.
  • Arrowgrass Capital Partners (US)'s Medtronic position peaked at $5.36M in Q3 2017.
  • 1,645 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2019, filed 14 Nov 2019.